共 48 条
Recombinant human erythropoietin produced in milk of transgenic pigs
被引:46
作者:
Park, JK
Lee, YK
Lee, P
Chung, HJ
Kim, S
Lee, HG
Seo, MK
Han, JH
Park, CG
Kim, HT
Kim, YK
Min, KS
Kim, JH
Lee, HT
Chang, WK
[1
]
机构:
[1] Natl Livestock Res Inst, Anim Biotechnol Div, Suwon 441706, South Korea
[2] In2gen Biotech Co Ltd, Seoul, South Korea
[3] Hankyang Natl Univ, Grad Sch Bio & Informat Technol, Ansung, South Korea
[4] Gyeongsang Natl Univ, Dept Dairy Sci, Chinju, South Korea
[5] Konkuk Univ, Dept Anim Sci, Seoul, South Korea
关键词:
erythropoietin;
transgenic animals;
microinjection;
mammary gland;
expression;
D O I:
10.1016/j.jbiotec.2005.11.021
中图分类号:
Q81 [生物工程学(生物技术)];
Q93 [微生物学];
学科分类号:
071005 ;
0836 ;
090102 ;
100705 ;
摘要:
We have developed a line of transgenic swine harboring recombinant human erythropoietin through microinjection into fertilized one cell pig zygotes. Milk from generations F(1) and F(2) transgenic females was analyzed, and hEPO was detected in milk from all lactating females at concentrations of approximately 877.9 +/- 92.8 IU/1 ml. The amino acid sequence of rhEPO protein in the transgenic pig milk matched that of commercial rhEPO produced from cultured animal cells. In addition, an F-36 cell line, which proliferates in the presence of hEPO or commercial EPO, was induced to synthesize erythroid by extracts from tg sow milk. This study provides evidence that production of purified rhEPO from transgenic pig milk is a potentially valuable technology, and can be used as a cost-effective alternative in clinical applications as well as providing other clinical advantages. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:362 / 371
页数:10
相关论文